This activity was originally broadcast as part of the 2024 Directions in Oncology Pharmacy® conference.
The patient cases discussion portion of the program also includes discussion on endometrial cancer.
Program Description
Immune checkpoint inhibitors are a type of immunotherapy used in the treatment of various tumor types, but they can cause unique immune-related adverse events (irAEs) that require pharmacist expertise. As these agents become more prevalent in the oncology treatment landscape, the roles of pharmacists will continue to expand to encompass patient monitoring, identifying, and managing irAEs. Early detection and treatment of irAEs has been shown to improve patient outcomes. This session will address concepts related to early irAE recognition in real-world clinical practice, management of reversible and irreversible irAEs, and patient education. The case discussions incorporated within this program will emphasize pharmacist-led initiatives to address challenges and barriers to the early identification of clinically significant irAEs, as well as best practices for short-term and long-term follow-up.
Target audience: Oncology pharmacists
Type of activity: Application
Release date: November 25, 2024
Expiration date: November 25, 2025
Time to complete activity: 1.0 hour
Learner level: Foundational, Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Apply knowledge of immune-related adverse events (irAE) characteristics, risk factors for development, and appropriate monitoring requirements to promptly identify toxicities of checkpoint inhibitor treatment
- Manage steroid tapers for individual patients, considering the type and severity of irAEs and patient characteristics
- Implement strategies for identification and management of immune-mediated endocrinopathies
- Provide comprehensive patient education on immune-related adverse events, stressing early recognition and reporting

Jordan McPherson, PharmD, MS, BCOP
Oncology Clinical Pharmacist
Huntsman Cancer Institute
Adjunct Associate Professor
University of Utah
Salt Lake City, Utah

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-328-H01-P. The activity is available for CE credit through November 25, 2025.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Jordan McPherson, PharmD, MS, BCOP
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Amy L. Morris, PharmD, BCOP; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
